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with regard to mortality no difference was observed in both the
groups (6.55% vs 5.44%, p = 0.23). Angiographic proﬁle showed
lower preponderance of single vessel disease (SVD) in MetS group
vis-à-vis without MetS group (29.52% vs 55.48%, p = 0.001). How-
ever, presence of double vessel disease (DVD), triple vessel disease
(TVD), and left main (LMCA) (42.28% vs 23.69%, 22.87% vs 9.82%,
12.38% vs 4.04%, p = 0.001) were more common in MetS group than
withoutMetS group. More complex coronary lesion (tubular 42.59%
vs 32.76% and diffuse 25.29% vs 15.79%, p = 0.01) were common in
MetS group than in patients without MetS group when compared
to simple coronary lesion (discrete 32.12% vs 51.45%, p = 0.01),
respectively.
Conclusion: Our study has identiﬁed the high prevalence of MetS
among patients with ACS in North Indian population. Also there is
trend ofmore advanced vascular damage (depending onnumber of
vessel and type of lesion involvement) in patients with MetS than
those without MetS. To the best our knowledge this is ﬁrst study
fromNorth India documenting the angiographic proﬁle of patients
with metabolic syndrome and ACS.
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Introduction: Coronary artery disease (CAD) is becoming a major
cause of morbidity and mortality burden in the developing world.
Indians have been associated with a more severe form of CAD that
has its onset at a younger age group with a male predominance.
The purpose of this study was to investigate and compare the
clinical characteristics and coronary angiographic features of
patients with acute myocardial infarction (AMI) of the age above
and below 40 years.
Methods:Wecollected data of 206 consecutive patientswith STEMI
from January 2013 to December 2013 at our institute (a tertiary care
center). The clinical history revealed information about age, gen-
der, risk factors, modes of presentation, and duration of symp-
toms. The regions of infarction and rhythm disturbances were also
documented. The subjects were evaluated for conventional risk
factors, i.e. smoking, diabetes mellitus, systemic hypertension,
and family history of premature CAD. Selective coronary angio-
graphy in multiple views was performed by standard technique to
deﬁne both the extent and severity of disease.
Results:Mean patient age was 49.39  10.45 years. All the patients
in less than 40 years age group presented with chest pain. In more
than 40 years age group, only 91% presented with chest pain
remaining with dyspnea and fatigue ( p < 0.021). Incidence of
AMI in less than 40 years age group was 29% ( p < 0.001).
Diabetes was present in 44% ( p < 0.001) and hypertension was
present in 35% ( p < 0.001) of study group; both of them were
common in more than 40 years age group. Incidence of dyslipide-
mia was 36% ( p < 0.095) common in less than 40 years age group.
Smoking, alcohol, and family history was common in less than 40
years age group ( p < 0.001).
AWMI was the most common MI with 51%. IWMI incidence
was 44%. Most of the patients had ejection fraction between
40 and 50%. SVD was most common with 55%. Recanalisation rate
of coronaries was 9% ( p < 0.001) and thrombus in coronaries seen
in 23%; both of themwere common in less than 40 years age group.
Total occlusion of coronaries seen in 12%. Pharmacoinvasive
angioplasty was the most common intervention done in 21%.
Conclusion: Clinical and angiographic proﬁle was different in age
above and below 40 years. Younger patients had lower prevalence
of diabetes and hypertension, smoking, and family history of
premature CAD was more common than older patients.
Prognostic value of NT-Pro-BNP in
prediction of left ventricular systolic
function and outcome of patients of
acute coronary syndrome
B.P. Chattopadhyay *, R. Ray, H. Rath, S. Singh,
S. Chatterjee
Department of Cardiology, Medical College & Hospital, Calcutta, India
Background: Role of NT-Pro-BNP in the diagnosis and differential
diagnosis of left ventricular failure is now established. The objec-
tive of the present study was to investigate the ability of the NT-
Pro-BNP level to predict LV systolic function, in-hospital mortality,
and post-discharge short term prognosis, in patients of acute
coronary syndrome.
Methods: Patients with acute coronary syndrome (n = 216) present-
ing with typical chest pain and labelled diagnosis of STEMI or
NSTEMI were included in the study. Measurement of NT-Pro-
BNP and Echo parameters were done on admission and at 72 h
as well. The patients were followed up in the OPD for a mean
period of 5.4 months (2.3–8.7 months) after hospital-stay of mean
8.3  1.2 days. The follow-up was terminated on reaching the
primary end point which were death, fatal or non-fatal MI (or
recurrent MI in patients with STEMI) or revascularization, or
admission for HF.
Results: Out of 216 patients enrolled in the study 104 (48%) had
STEMI and 112 (51.9%) hadNSTEMI. Amongst the STEMI patients 92
(88.4%) received thrombolysis and the rest did not receive throm-
bolysis either due to late presentation or contraindication(s). Mean
time-window of thrombolysis was 6.7  1.3 h (3.2–11.7 h). STEMI
patients had Killip class I 73 (70.1%), class II 23 (22.1%), class III 6
(5.7%), and class IV 2 (1.9%). The patients in both STEMI and
NSTEMI groups were divided according to the NT-Pro-BNP values.
The patients in each category were divided into two groups, one in
the high tertile and the other consisting of low tertiles. The char-
acteristics and follow up outcomes were compared in the two
groups, high NT-Pro-BNP group and low NT-Pro-BNP group. STEMI
patients having highNT-Pro-BNP level tended to be onhigher Killip
class than others. Mean LVEF measured after 3 days were signiﬁ-
cantly lower in patients of both forms of ACS having higher NT-
Pro-BNP values ( p < 0.05). In-hospital mortality was signiﬁcantly
higher in STEMI patients having higher NT-pro-BNP values (5.5% vs
4.4%, p < 0.05) whereas this trend was not evident in NSTEMI
patients (4.5% vs 4.4%, p = NS). During follow-up, recurrent MI,
admission due to heart failure and death out of hospital due to
any cause were signiﬁcantly higher in both groups of patients
having high NT-Pro-BNP values. Patients with high NT-Pro-BNP
values had more multivessel CAD (2 or 3-vessel involvement)
compared to those with low NT-Pro-BNP level (80% vs 65.2%,
p < 0.05), whereas, patients with low NT-Pro-BNP values had more
single vessel disease (31.9% vs 20%, p < 0.005). Patients having high
values had more chance of having LAD involvements (56% vs
44.7%, p < 0.05) compared to others with lower values.
Conclusion: High NT-Pro-BNP level is associated with signiﬁcantly
lower LVEF and poorer outcome in patients of both forms of ACS
( p < 0.05) but STEMI group correlated better than the NSTEMI
group. So NT-Pro-BNP level (either on admission or at 72 h) is
important in prediction of LV systolic function and outcome of
patients of acute coronary syndrome. Single estimation of NT-Pro-
BNP level on admission alone is sufﬁcient for this purpose.
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